Neuren Pharmaceuticals Ltd
ASX:NEU
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Neuren Pharmaceuticals Ltd
ASX:NEU
|
AU |
|
Vivid Seats Inc
NASDAQ:SEAT
|
US |
|
Soko Seiren Co Ltd
TSE:3578
|
JP |
|
Yojee Ltd
ASX:YOJ
|
AU |
|
I
|
International Container Terminal Services Inc
XPHS:ICT
|
PH |
Wall Street
Price Targets
NEU Price Targets Summary
Neuren Pharmaceuticals Ltd
According to Wall Street analysts, the average 1-year price target for
NEU
is 23.94 AUD
with a low forecast of 18.58 AUD and a high forecast of 30.45 AUD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is NEU's stock price target?
Price Target
23.94
AUD
According to Wall Street analysts, the average 1-year price target for
NEU
is 23.94 AUD
with a low forecast of 18.58 AUD and a high forecast of 30.45 AUD.
What is Neuren Pharmaceuticals Ltd's Revenue forecast?
Projected CAGR
38%
For the last 14 years the
compound annual growth rate for
Neuren Pharmaceuticals Ltd's revenue is
25%.
The projected
CAGR
for the next 3 years is
38%.
What is Neuren Pharmaceuticals Ltd's Operating Income forecast?
Projected CAGR
63%
The
compound annual growth rate
of Neuren Pharmaceuticals Ltd's operating income for the next 3 years is
63%.
What is Neuren Pharmaceuticals Ltd's Net Income forecast?
Projected CAGR
88%
The
compound annual growth rate
of Neuren Pharmaceuticals Ltd's net income for the next 3 years is
88%.
